IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based study

Patients with chronic lymphocytic leukemia and unmutated immunoglobulin heavy-chain variable region gene (IGHV) have inferior survival from time of treatment in clinical studies. We assessed real-world outcomes based on mutational status and treatment regimen in a nationwide population-based cohort,...

Descripción completa

Detalles Bibliográficos
Autores principales: Rotbain, Emelie Curovic, Frederiksen, Henrik, Hjalgrim, Henrik, Rostgaard, Klaus, Egholm, Gudrun Jakubsdottir, Zahedi, Banafsheh, Poulsen, Christian Bjørn, Enggard, Lisbeth, da Cunha-Bang, Caspar, Niemann, Carsten Utoft
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271602/
https://www.ncbi.nlm.nih.gov/pubmed/31582540
http://dx.doi.org/10.3324/haematol.2019.220194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271602/
https://www.ncbi.nlm.nih.gov/pubmed/31582540
http://dx.doi.org/10.3324/haematol.2019.220194

Ejemplares similares